Allergy/Asthma News

Medicine was an interesting thought as I was growing up with no medical people in my family.

The FDA has approved Palforzia, an oral immunotherapy designed to protect children aged 1 to 3 years with peanut allergies from reactions caused by accidental exposure, according to a press release.

Researchers traced childhood illnesses like asthma, frequent head colds and tonsilitis to the development of chronic rhinosinusitis in middle age in a population-based study.

A recent study found that health care professionals were increasingly able to identify infants and young children with anaphylaxis by following modified criteria.

A crossover study revealed that dry powder epinephrine administered via nasal spray yielded drug exposures equal to or higher than those provided by autoinjectors in a canine model.

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended marketing authorization of ARS Pharmaceuticals’ EURneffy epinephrine nasal spray in the European Union, according to a press release.

Recent comments from In-N-Out Burger chain owner and president Lynsi Snyder regarding the company’s inclusion of sesame flour in its buns has sparked concern from leading allergy advocacy organizations and specialists.

A panel of experts agreed that vaccines can be safe and effective in patients receiving dupilumab, although they said that physicians should engage with patients in decision-making before vaccination.

H.R. 3935, a bill signed into law on May 16 by President Joe Biden, includes a clause stating that the Federal Aviation Administration must reconsider medications and protocol for emergency treatment of anaphylaxis on airplanes.

Feeding children peanut products from infancy to age 5 years reduced the prevalence of peanut allergy into adolescence, according to recent data.